Search for Clinical Trial Results

Lymphoma, Primary Cutaneous Anaplastic Large Cell - 8 Studies Found
Status | Study |
Withdrawn |
Study Name: MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma Condition: Lymphoma, Large-Cell Date: 2006-03-01 Interventions: Drug: MDX-060 |
Completed |
Study Name: Study of SGN-30 (Anti-CD30 mAb) in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma Condition: Large Cell Lymphoma Date: 2004-12-10 Interventions: Drug: SGN-30 |
Active, not recruiting |
Study Name: A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Patients With CD30-Positive Cutaneous T-Cell Lymphoma Condition:
|
Completed |
Study Name: Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma Condition:
|
Active, not recruiting |
Study Name: SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP) Condition:
|
Recruiting |
Study Name: Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma Condition:
Interventions: |
Recruiting |
Study Name: Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency Condition:
|
Recruiting |
Study Name: Multicentre Phase I Trial of Engineered T Cells for Patients With Relapsed or Refractory Primary Cutaneous CD30+ Large T Cell Lymphoma or Transformed CD30+ Mycosis Fungoides Condition:
Interventions: Genetic: Genetically modified T cells # 1138 |